WUXIAN EXPRESS Trademark

Trademark Overview

On Wednesday, November 25, 2020, a trademark application was filed for WUXIAN EXPRESS with the United States Patent and Trademark Office. The USPTO has given the WUXIAN EXPRESS trademark a serial number of 90343137. The federal status of this trademark filing is REGISTERED as of Tuesday, November 8, 2022. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The WUXIAN EXPRESS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies
wuxian express

General Information

Serial Number90343137
Word MarkWUXIAN EXPRESS
Filing DateWednesday, November 25, 2020
Status700 - REGISTERED
Status DateTuesday, November 8, 2022
Registration Number6896092
Registration DateTuesday, November 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Pseudo MarkWU XIAN EXPRESS
Translation of Words in MarkThe English translation of WUXIAN in the mark is "infinite".
Goods and Servicesproduct development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 1, 2021
Primary Code042
First Use Anywhere DateSaturday, August 6, 2022
First Use In Commerce DateSaturday, August 6, 2022

Trademark Owner History

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE
Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE
Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE

Trademark Events

Event DateEvent Description
Tuesday, November 8, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 8, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, October 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, August 26, 2022USE AMENDMENT FILED
Friday, September 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 26, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 1, 2021NON-FINAL ACTION E-MAILED
Monday, November 1, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 11, 2021NON-FINAL ACTION E-MAILED
Tuesday, May 11, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 11, 2021ASSIGNED TO EXAMINER
Monday, February 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 28, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

express wuxian development research pharmaceutical services biomedical analysis science antibodies biochemical preparations